Efficacy and safety of a topical skincare regimen containing CE Ferulic serum and resveratrol BE serum following ablative fractional CO2 laser treatment: A prospective, randomized, split-face, controlled trial

被引:3
|
作者
Shi, Yu [1 ]
Shen, Chen [1 ]
Zhang, Wei [1 ]
机构
[1] Tongji Univ, Shanghai Skin Dis Hosp, Sch Med, Dept Med Cosmetol, 1278 Baode Rd, Shanghai 200443, Peoples R China
关键词
VITAMIN-C; PHOTOPROTECTION;
D O I
10.1111/jdv.20070
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Ablative fractional CO2 laser is widely used to address various skin problems, but the treatment often leads to adverse effects such as erythema, dyspigmentation, and extended recovery periods, negatively impacting patients' quality of life. Objectives: This study aimed to evaluate the efficacy and safety of a topical skincare regimen containing both CE Ferulic serum and Resveratrol BE night serum following fractional CO2 laser treatment in Chinese population. Methods: In this randomized, investigator-blinded, split-face, controlled trial, individuals aged 18-65 undergoing ablative CO2 laser treatment were randomly assigned to apply CE Ferulic plus resveratrol BE serum (CEF-RBE) to either side of face and normal saline (NS) to the other, for 14 consecutive days. The primary endpoint was erythema index (EI) on day 14, with key secondary endpoints including scabbing detachment time, percentage changes in EI and melanin index (MI), skin hydration, transepidermal water loss, skin sebum content, oedema, and overall subject satisfaction. Results: The study included 51 patients, of whom 29 (56.9%) were female, with a mean (SD) age of 29.8 (5.39) years. On day 14, the CEF-RBE side exhibited significantly lower EI than the NS side (308.9 vs. 325.3, p = 0.034). The median (IQR) time (days) for complete scabbing detachment at the CEF-RBE side was 6.0 (5.0-8.0) compared to 6.5 (5.0-9.0) at NS side (p = 0.018). Additionally, the CEF-RBE side showed a 7.4% decrease in MI from baseline to day 14, while the NS side experienced a 0.2% increase (Delta = -7.6%, p = 0.044). Throughout the 14-day follow-up, the CEF-RBE side consistently displayed higher skin hydration than the NS side. Conclusions: The study highlighted the benefits of incorporating CEF-RBE following laser treatment in reducing erythema and hyperpigmentation, promoting wound healing, and maintaining skin hydration, although limitations such as contamination and adherence issues should be considered.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 50 条
  • [41] Efficacy and safety of the 589/1319 nm solid-state dual-wavelength laser combined with topical benzoyl peroxide for inflammatory acne vulgaris: a split-face randomized controlled trial
    Boonpethkaew, Suphagan
    Ratanapokasatit, Yanisa
    Chirasuthat, Sonphet
    Wattanakrai, Penpun
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [42] Combination treatment with adipose stem cell exosomes (ASCE) and fractional co2 laser for acne scars: a 12-week prospective, double-blind, randomized, split-face study
    Cho, B. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S335 - S335
  • [43] Efficacy and safety of a novel picosecond laser using combination of 1064 and 595nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial
    Choi, Young-Jun
    Nam, Jae-Hui
    Kim, Jung Yup
    Min, Joon Hong
    Park, Kui Young
    Ko, Eun Jung
    Kim, Beom Joon
    Kim, Won-Serk
    LASERS IN SURGERY AND MEDICINE, 2017, 49 (10) : 899 - 907
  • [44] Fractional CO2 laser alone versus combined with topical timolol or insulin for acne Scar treatment: a randomized controlled clinical trial
    Nasrin Saki
    Sara Alavizadeh
    Mohammad Mahdi Parvizi
    Mohammad Kamali
    Lasers in Medical Science, 40 (1)
  • [45] The efficacy of fractional carbon dioxide (CO2) laser combined with luliconazole 1% cream for the treatment of onychomycosis A randomized, controlled trial
    Zhou, Bing Rong
    Lu, Yan
    Permatasari, Felicia
    Huang, He
    Li, Jin
    Liu, Juan
    Zhang, Jia An
    Luo, Dan
    Xu, Yang
    MEDICINE, 2016, 95 (44)
  • [46] The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study
    Wanitphakdeedecha, Rungsima
    Sy-Alvarado, Francesca
    Patthamalai, Poramin
    Techapichetvanich, Thanya
    Eimpunth, Sasima
    Manuskiatti, Woraphong
    LASERS IN MEDICAL SCIENCE, 2020, 35 (09) : 2015 - 2021
  • [47] THE EFFICACY IN TREATMENT OF FACIAL MELASMA WITH THULIUM 1927nm FRACTIONAL LASER-ASSISTED TOPICAL TRANEXAMIC ACID DELIVERY: A SPLIT-FACE, DOUBLE-BLIND, RANDOMIZED CONTROLLED PILOT STUDY
    Sy-Alvarado, Francesca Mari S.
    Wanitphakdeedecha, Rungsima
    Manuskiatti, Woraphong
    Eimpunth, Sasima
    Techapichetvanich, Thanya
    Patthamalai, Poramin
    LASERS IN SURGERY AND MEDICINE, 2019, 51 : S27 - S28
  • [48] The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study
    Rungsima Wanitphakdeedecha
    Francesca Sy-Alvarado
    Poramin Patthamalai
    Thanya Techapichetvanich
    Sasima Eimpunth
    Woraphong Manuskiatti
    Lasers in Medical Science, 2020, 35 : 2015 - 2021
  • [49] Efficacy of stem cell-conditioned medium vs. platelet-rich plasma as an adjuvant to ablative fractional CO2 laser resurfacing for atrophic post-acne scars: a split-face clinical trial
    Abdel-Maguid, Ensaf M.
    Awad, Sara M.
    Hassan, Youssef S.
    El-Mokhtar, Mohamed A.
    EL-Deek, Heba Em
    Mekkawy, Marwa Ma
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (02) : 242 - 249
  • [50] Evaluating the efficacy of combining fractional CO2 laser and topical tranexamic acid for burn scar and hyperpigmentation treatment: A prospective, randomized, single-blinded, split-body study
    Huang, Ching-Ya
    Lin, Cen-Hung
    Tsai, Yueh-Ju
    Lin, Ko-Chien
    Kuo, Spencer Chia-Hao
    Wong, Lai-San
    Lin, Hui-Ping
    Hsieh, Ching-Hua
    DERMATOLOGICA SINICA, 2024, 42 (04) : 265 - 272